Clinical Trial Update: Circadian Ocular Perfusion Pressure and Ocular Blood Flow [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Alcon Research evaluating circadian ocular perfusion pressure and ocular blood flow in glaucoma. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2013-03-22